IR-Med (IRME) Shares Outstanding (Weighted Average) (2020 - 2025)

IR-Med has disclosed Shares Outstanding (Weighted Average) across 6 years of filings, most recently posting $72.4 million for Q2 2025.

• Shares Outstanding (Weighted Average) for Q2 2025 came in at $72.4 million, up 3.3% year-over-year; the trailing twelve-month figure through Jun 2025 was $72.4 million (up 3.3% YoY), and the FY2024 annual result was $71.0 million, up 2.31% from the prior year.
• Shares Outstanding (Weighted Average) came in at $72.4 million for Q2 2025 at IR-Med, up from $3.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $72.4 million in Q2 2025 to a low of $3.6 million in Q1 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $68.8 million (2022), against an average of $64.1 million.
• Across the five-year window, Shares Outstanding (Weighted Average) surged 111.61% in 2021 and tumbled 94.8% in 2025, its largest moves.
• IR-Med's Shares Outstanding (Weighted Average) stood at $63.1 million in 2021, then advanced by 7.08% to $67.6 million in 2022, then climbed by 2.7% to $69.4 million in 2023, then increased by 2.31% to $71.0 million in 2024, then increased by 1.99% to $72.4 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $72.4 million (Q2 2025), $3.6 million (Q1 2025), and $71.0 million (Q4 2024), per Business Quant data.